Sciele Pharma Investor Relations

Stock Information
   Stock Quote
   Stock Chart
   Historical Lookup
   Stock Calculator

Financial Information
   SEC Filings
   Annual Report
   Fundamentals

News and Events
   News Releases
   Event Calendar
   Webcasts & Presentations

Shareholder Information
   Analyst Coverage
   Earnings Estimates
   Transfer Agent

Corporate Governance
   Corporate Documents
   Management Team
   Board of Directors
   Committee Composition
   Guidelines
   Conduct
   Committee Charters

Request Information
   Information Request
   Contact Information
   Email Alert

Investor Relations
Investors Overview
Webcast
Sciele Management Call to Discuss Shionogi Acquisition (Replay)
09/02/08 at 12:00 p.m. ET
Corporate Profile
About Sciele Pharma
Sciele Pharma, Inc. is a pharmaceutical company specializing in sales, marketing and development of branded prescription products focused on Cardiovascular/Diabetes, Women's Health and Pediatrics. The Company's Cardiovascular/Diabetes products treat patients with high cholesterol, hypertension, high triglycerides, unstable angina and Type 2 diabetes; its Women's Health products are designed to improve the health and well-being of women and mothers and their babies; and its Pediatrics products treat allergies, asthma, coughs and colds, and attention deficit/hyperactivity disorder (ADHD). Founded in 1992 and headquartered in Atlanta, Georgia, Sciele Pharma employs more than 900 people. The Company's success is based on placing the needs of patients first, improving health and quality of life, and implementing its business platform - an Entrepreneurial Spirit, Innovation, Speed of ... More >>
Today's Quote
Data as of 09/05/08 4:00 p.m. ET
SCRX (Common Stock)
Exchange NASDAQ (US Dollar)
Price $30.73
Change (%) 0.07 (0.23%)
Volume 2,560,236
Minimum 20 minute delay
Refresh quote
Featured Report
Title: 2007 Annual Report
Receive E-mail Alerts
Alerts are e-mailed to you whenever certain new company information is posted to this site.
Sign-up Now!
Recent News More >>
Date Title
09/01/08 Shionogi & Co., Ltd. to Acquire Sciele Pharma, Inc.
07/30/08 Sciele Pharma, Inc. Reports Results for the Second Quarter of 2008
07/16/08 Sciele Pharma Announces That the FDA Has Issued an Approvable Letter for the Head Lice Treatment
07/15/08 Sciele Pharma Announces Second Quarter 2008 Earnings Release Date and Conference Call

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.